# Zillow Group, Inc.: financial statements, quarterly ZG · Nasdaq · CIK 1617640 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/zg.md) · [Financials](/companies/zg/financials.md) · [Filings](/companies/zg/filings.md) · [Insiders](/companies/zg/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/zg/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [496](/filings/0001617640-24-000126.md) | [474 d](/filings/0001617640-26-000015.md) | [529](/filings/0001617640-25-000064.md) | [572](/filings/0001617640-25-000094.md) | [581](/filings/0001617640-25-000150.md) | [554 d](/filings/0001617640-26-000015.md) | [598](/filings/0001617640-26-000039.md) | [655](/filings/0001617640-26-000052.md) | [676](/filings/0001617640-25-000150.md) | [654 d](/filings/0001617640-26-000015.md) | [708](/filings/0001617640-26-000039.md) | [772](/filings/0001617640-26-000052.md) | | Cost of revenue | $m | [110](/filings/0001617640-24-000126.md) | [115 d](/filings/0001617640-26-000015.md) | [123](/filings/0001617640-25-000064.md) | [130](/filings/0001617640-25-000094.md) | [140](/filings/0001617640-25-000150.md) | [134 d](/filings/0001617640-26-000015.md) | [139](/filings/0001617640-26-000039.md) | [166](/filings/0001617640-26-000052.md) | [185](/filings/0001617640-25-000150.md) | [178 d](/filings/0001617640-26-000015.md) | [189](/filings/0001617640-26-000039.md) | [210](/filings/0001617640-26-000052.md) | | Gross profit | $m | [386](/filings/0001617640-24-000126.md) | [359 d](/filings/0001617640-26-000015.md) | [406](/filings/0001617640-25-000064.md) | [442](/filings/0001617640-25-000094.md) | [441](/filings/0001617640-25-000150.md) | [420 d](/filings/0001617640-26-000015.md) | [459](/filings/0001617640-26-000039.md) | [489](/filings/0001617640-26-000052.md) | [491](/filings/0001617640-25-000150.md) | [476 d](/filings/0001617640-26-000015.md) | [519](/filings/0001617640-26-000039.md) | [562](/filings/0001617640-26-000052.md) | | Research and development | $m | [142](/filings/0001617640-24-000126.md) | [141 d](/filings/0001617640-26-000015.md) | [147](/filings/0001617640-25-000064.md) | [144](/filings/0001617640-25-000094.md) | [145](/filings/0001617640-25-000150.md) | [149 d](/filings/0001617640-26-000015.md) | [149](/filings/0001617640-26-000039.md) | [153](/filings/0001617640-26-000052.md) | [151](/filings/0001617640-25-000150.md) | [154 d](/filings/0001617640-26-000015.md) | [150](/filings/0001617640-26-000039.md) | [156](/filings/0001617640-26-000052.md) | | Operating income | $m | [(53.0)](/filings/0001617640-24-000126.md) | [(105) d](/filings/0001617640-26-000015.md) | [(45.0)](/filings/0001617640-25-000064.md) | [(38.0)](/filings/0001617640-25-000094.md) | [(45.0)](/filings/0001617640-25-000150.md) | [(69.0) d](/filings/0001617640-26-000015.md) | [(9.0)](/filings/0001617640-26-000039.md) | [(11.0)](/filings/0001617640-26-000052.md) | [(3.0)](/filings/0001617640-25-000150.md) | [(11.0) d](/filings/0001617640-26-000015.md) | [36.0](/filings/0001617640-26-000039.md) | [(10.0)](/filings/0001617640-26-000052.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [0.0](/filings/0001617640-24-000126.md) | [3.0 d](/filings/0001617640-26-000015.md) | [2.0](/filings/0001617640-25-000064.md) | [2.0](/filings/0001617640-25-000094.md) | [0.0](/filings/0001617640-25-000150.md) | [1.0 d](/filings/0001617640-26-000015.md) | [0.0](/filings/0001617640-26-000039.md) | [0.0](/filings/0001617640-26-000052.md) | [2.0](/filings/0001617640-25-000150.md) | [0.0 d](/filings/0001617640-26-000015.md) | [2.0](/filings/0001617640-26-000039.md) | [1.0](/filings/0001617640-26-000052.md) | | Net income | $m | [(28.0)](/filings/0001617640-24-000126.md) | [(73.0) d](/filings/0001617640-26-000015.md) | [(23.0)](/filings/0001617640-25-000064.md) | [(17.0)](/filings/0001617640-25-000094.md) | [(20.0)](/filings/0001617640-25-000150.md) | [(52.0) d](/filings/0001617640-26-000015.md) | [8.0](/filings/0001617640-26-000039.md) | [2.0](/filings/0001617640-26-000052.md) | [10.0](/filings/0001617640-25-000150.md) | [3.0 d](/filings/0001617640-26-000015.md) | [46.0](/filings/0001617640-26-000039.md) | [(4.0)](/filings/0001617640-26-000052.md) | | Diluted EPS | $ per share | [(0.12)](/filings/0001617640-24-000126.md) | not reported | [(0.10)](/filings/0001617640-25-000064.md) | [(0.07)](/filings/0001617640-25-000094.md) | [(0.08)](/filings/0001617640-25-000150.md) | not reported | [0.03](/filings/0001617640-26-000039.md) | [0.01](/filings/0001617640-26-000052.md) | [0.04](/filings/0001617640-25-000150.md) | not reported | [0.19](/filings/0001617640-26-000039.md) | [(0.02)](/filings/0001617640-26-000052.md) | | Basic EPS | $ per share | [(0.12)](/filings/0001617640-24-000126.md) | not reported | [(0.10)](/filings/0001617640-25-000064.md) | [(0.07)](/filings/0001617640-25-000094.md) | [(0.08)](/filings/0001617640-25-000150.md) | not reported | [0.03](/filings/0001617640-26-000039.md) | [0.01](/filings/0001617640-26-000052.md) | [0.04](/filings/0001617640-25-000150.md) | not reported | [0.19](/filings/0001617640-26-000039.md) | [(0.02)](/filings/0001617640-26-000052.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [1,846](/filings/0001617640-23-000110.md) | [1,492](/filings/0001617640-25-000016.md) | [1,439](/filings/0001617640-24-000070.md) | [1,181](/filings/0001617640-24-000094.md) | [1,072](/filings/0001617640-24-000126.md) | [1,082](/filings/0001617640-26-000015.md) | [914](/filings/0001617640-25-000064.md) | [587](/filings/0001617640-25-000094.md) | [874](/filings/0001617640-25-000150.md) | [768](/filings/0001617640-26-000052.md) | [678](/filings/0001617640-26-000039.md) | [572](/filings/0001617640-26-000052.md) | | Current assets | $m | [3,612](/filings/0001617640-23-000110.md) | [3,149](/filings/0001617640-25-000016.md) | [3,322](/filings/0001617640-24-000070.md) | [3,129](/filings/0001617640-24-000094.md) | [2,669](/filings/0001617640-24-000126.md) | [2,334](/filings/0001617640-26-000015.md) | [2,154](/filings/0001617640-25-000064.md) | [1,821](/filings/0001617640-25-000094.md) | [2,119](/filings/0001617640-25-000150.md) | [2,122](/filings/0001617640-26-000052.md) | [1,659](/filings/0001617640-26-000039.md) | [1,741](/filings/0001617640-26-000052.md) | | Total assets | $m | [6,656](/filings/0001617640-23-000110.md) | [6,652](/filings/0001617640-25-000016.md) | [6,823](/filings/0001617640-24-000070.md) | [6,628](/filings/0001617640-24-000094.md) | [6,159](/filings/0001617640-24-000126.md) | [5,829](/filings/0001617640-26-000015.md) | [5,746](/filings/0001617640-25-000064.md) | [5,416](/filings/0001617640-25-000094.md) | [5,698](/filings/0001617640-25-000150.md) | [5,685](/filings/0001617640-26-000052.md) | [5,226](/filings/0001617640-26-000039.md) | [5,305](/filings/0001617640-26-000052.md) | | Current liabilities | $m | [941](/filings/0001617640-23-000110.md) | [971](/filings/0001617640-25-000016.md) | [1,001](/filings/0001617640-24-000070.md) | [1,478](/filings/0001617640-24-000094.md) | [854](/filings/0001617640-24-000126.md) | [831](/filings/0001617640-26-000015.md) | [875](/filings/0001617640-25-000064.md) | [546](/filings/0001617640-25-000094.md) | [584](/filings/0001617640-25-000150.md) | [679](/filings/0001617640-26-000052.md) | [724](/filings/0001617640-26-000039.md) | [906](/filings/0001617640-26-000052.md) | | Total liabilities | $m | [2,127](/filings/0001617640-23-000110.md) | [2,126](/filings/0001617640-25-000016.md) | [2,158](/filings/0001617640-24-000070.md) | [2,127](/filings/0001617640-24-000094.md) | [1,503](/filings/0001617640-24-000126.md) | [981](/filings/0001617640-26-000015.md) | [992](/filings/0001617640-25-000064.md) | [670](/filings/0001617640-25-000094.md) | [706](/filings/0001617640-25-000150.md) | [801](/filings/0001617640-26-000052.md) | [818](/filings/0001617640-26-000039.md) | [997](/filings/0001617640-26-000052.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [4,529](/filings/0001617640-24-000126.md) | [4,526](/filings/0001617640-26-000015.md) | [4,665](/filings/0001617640-25-000094.md) | [4,501](/filings/0001617640-25-000150.md) | [4,656](/filings/0001617640-25-000150.md) | [4,848](/filings/0001617640-26-000052.md) | [4,754](/filings/0001617640-26-000052.md) | [4,746](/filings/0001617640-26-000052.md) | [4,992](/filings/0001617640-25-000150.md) | [4,884](/filings/0001617640-26-000052.md) | [4,408](/filings/0001617640-26-000052.md) | [4,308](/filings/0001617640-26-000052.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [75.0 d](/filings/0001617640-24-000126.md) | [86.0 d](/filings/0001617640-26-000015.md) | [80.0](/filings/0001617640-25-000064.md) | [55.0 d](/filings/0001617640-25-000094.md) | [171 d](/filings/0001617640-25-000150.md) | [122 d](/filings/0001617640-26-000015.md) | [104](/filings/0001617640-26-000039.md) | [87.0 d](/filings/0001617640-26-000052.md) | [105 d](/filings/0001617640-25-000150.md) | [72.0 d](/filings/0001617640-26-000015.md) | [200](/filings/0001617640-26-000039.md) | [11.0 d](/filings/0001617640-26-000052.md) | | Capital expenditure | $m | [35.0 d](/filings/0001617640-24-000126.md) | [34.0 d](/filings/0001617640-26-000015.md) | [39.0](/filings/0001617640-25-000064.md) | [37.0 d](/filings/0001617640-25-000094.md) | [33.0 d](/filings/0001617640-25-000150.md) | [34.0 d](/filings/0001617640-26-000015.md) | [36.0](/filings/0001617640-26-000039.md) | [37.0 d](/filings/0001617640-26-000052.md) | [32.0 d](/filings/0001617640-25-000150.md) | [28.0 d](/filings/0001617640-26-000015.md) | [34.0](/filings/0001617640-26-000039.md) | [36.0 d](/filings/0001617640-26-000052.md) | | Share repurchases | $m | [100 d](/filings/0001617640-24-000126.md) | [88.0 d](/filings/0001617640-26-000015.md) | [9.0](/filings/0001617640-25-000064.md) | [292 d](/filings/0001617640-25-000094.md) | [0.0 d](/filings/0001617640-25-000150.md) | [0.0 d](/filings/0001617640-26-000015.md) | [250](/filings/0001617640-26-000039.md) | [150 d](/filings/0001617640-26-000052.md) | [38.0 d](/filings/0001617640-25-000150.md) | [232 d](/filings/0001617640-26-000015.md) | [626](/filings/0001617640-26-000039.md) | [200 d](/filings/0001617640-26-000052.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [240](/filings/0001617640-23-000110.md) | [234](/filings/0001617640-24-000070.md) | [234](/filings/0001617640-24-000094.md) | [233](/filings/0001617640-24-000126.md) | [235](/filings/0001617640-25-000064.md) | [233](/filings/0001617640-25-000094.md) | [233](/filings/0001617640-25-000150.md) | [256](/filings/0001617640-26-000039.md) | [252](/filings/0001617640-26-000052.md) | [256](/filings/0001617640-25-000150.md) | [240](/filings/0001617640-26-000039.md) | [228](/filings/0001617640-26-000052.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.